Vitamin E improves transaminitis in patients with concomitant type 2 diabetes and fatty liver

被引：0
|
作者：
Wai, D. [1 ]
Soh, A. [1 ]
Tham, K-W [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [21] The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Dai, Chia-Yen
    Fang, Tzu-Jung
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    BIOMEDICINES, 2022, 10 (07)
  • [22] Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels
    Sugden, J. A.
    Davies, J. I.
    Witham, M. D.
    Morris, A. D.
    Struthers, A. D.
    DIABETIC MEDICINE, 2008, 25 (03) : 320 - 325
  • [23] The use of vitamin E in type 2 diabetes mellitus
    Fardoun, Riham Zein
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2007, 29 (03) : 135 - 148
  • [24] Gliflozine in Type 2 Diabetes and Fatty Liver Disease
    Kahl, S.
    DIABETOLOGIE, 2022, 18 (05): : 665 - 666
  • [25] Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease
    Kadayifci, A
    Merriman, RB
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (06): : 1396 - 1396
  • [26] Plasma Fatty Acid Composition Is Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients
    Higa, Mariko
    Ichijo, Takamasa
    DIABETES, 2022, 71
  • [27] Pioglitazone Improves Atherosclerosis-Related Biomarkers Independent of Obesity in Japanese Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Suzuki, Yoshifumi
    Hashimoto, Naotake
    Sakuma, Yukie
    Iwai, Rie
    Tagui, Masako
    Yoshida, Shohji
    DIABETES, 2010, 59 : A568 - A568
  • [28] THE EMPACT OF VITAMIN E ON GLYCEMIC CONTROL AND LIPID PROFILES IN TYPE 2 DIABETES PATIENTS
    Mousavi Shirazi Fard, Zahra
    Mazloum, Zohreh
    Shab-Bidar, Sakineh
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 488 - 488
  • [29] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
  • [30] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Pennisi, G.
    Enea, M.
    Falco, V.
    Aithal, G. P.
    Palaniyappan, N.
    Yilmaz, Y.
    Boursier, J.
    Cassinotto, C.
    De Ledinghen, V.
    Chan, W. K.
    Mahadeva, S.
    Eddowes, P.
    Newsome, P.
    Karlas, T.
    Wiegand, J.
    Wong, V. Wai-Sun
    Schattenberg, J. M.
    Labenz, C.
    Kim, W.
    Lee, M. S.
    Lupsor-Platon, M.
    Cobbold, J. F. L.
    Fan, J.
    Shen, F.
    Staufer, K.
    Trauner, M.
    Stauber, R.
    Nakajima, A.
    Yoneda, M.
    Bugianesi, E.
    Younes, R.
    Gaia, S.
    Zheng, M.
    Camma, C.
    Anstee, Q. M.
    Mozes, F. E.
    Pavlides, M.
    Petta, S.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S12 - S13
12345